MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 104 filers reported holding MERUS N V in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $369 | -48.8% | 14,021 | -69.9% | 0.00% | 0.0% |
Q4 2022 | $721 | -100.0% | 46,600 | -35.5% | 0.00% | -50.0% |
Q3 2022 | $1,446,000 | +23.9% | 72,200 | +96.7% | 0.00% | +100.0% |
Q4 2021 | $1,167,000 | +7.3% | 36,704 | -25.8% | 0.00% | 0.0% |
Q3 2021 | $1,088,000 | -43.5% | 49,476 | -45.8% | 0.00% | -50.0% |
Q2 2021 | $1,924,000 | +19.7% | 91,325 | +18.6% | 0.00% | 0.0% |
Q1 2021 | $1,608,000 | +269.7% | 76,988 | +210.4% | 0.00% | – |
Q4 2020 | $435,000 | +81.2% | 24,800 | +66.4% | 0.00% | – |
Q2 2020 | $240,000 | +33.3% | 14,900 | 0.0% | 0.00% | – |
Q1 2020 | $180,000 | -25.6% | 14,900 | -13.4% | 0.00% | – |
Q4 2019 | $242,000 | +27.4% | 17,200 | +32.3% | 0.00% | – |
Q2 2019 | $190,000 | -19.5% | 13,000 | -18.8% | 0.00% | – |
Q1 2019 | $236,000 | -50.2% | 16,000 | -33.3% | 0.00% | – |
Q3 2018 | $474,000 | -73.7% | 24,000 | -72.2% | 0.00% | -100.0% |
Q2 2018 | $1,801,000 | +155.8% | 86,200 | +126.8% | 0.00% | 0.0% |
Q1 2018 | $704,000 | +28.2% | 38,000 | +68.9% | 0.00% | 0.0% |
Q1 2017 | $549,000 | – | 22,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |